Browse > Article

Recent Progress in Drug Delivery Systems for Anticancer Agents  

Kim, Chong-Kook (National Research Lab for Drug and Gene Delivery, College of Pharmacy, Seoul National University)
Lim, Soo-Jeong (National Research Lab for Drug and Gene Delivery, College of Pharmacy, Seoul National University)
Publication Information
Archives of Pharmacal Research / v.25, no.3, 2002 , pp. 229-239 More about this Journal
Abstract
Recent progress in understanding the molecular basis of cancer brought out new materials such as oligonucleotides, genes, peptides and proteins as a source of new anticancer agents. Due to their macromolecular properties, however, new strategies of delivery for them are required to achieve their full therapeutic efficacy in clinical setting. Development of improved dosage forms of currently marketed anticancer drugs can also enhance their therapeutic values. Currently developed delivery systems for anticancer agents include colloidal systems (liposomes, emulsions, nanoparticles and micelles), polymer implants and polymer conjugates. These delivery systems have been able to provide enhanced therapeutic activity and reduced toxicity of anticancer agents mainly by altering their pharmacokinetics and biodistribution. Furthermore, the identification of cell-specific receptor/antigens on cancer cells have brought the development of ligand- or antibody-bearing delivery systems which can be targeted to cancer cells by specific binding to receptors or antigens. They have exhibited specific and selective delivery of anticancer agents to cancer. As a consequence of extensive research, clinical development of anticancer agents utilizing various delivery systems is undergoing worldwide. New technologies and multidisciplinary expertise to develop advanced drug delivery systems, applicable to a wide range of anticancer agents, may eventually lead to an effective cancer therapy in the future.
Keywords
Drug delivery system; Anticancer Agents; Targeted delivery system;
Citations & Related Records

Times Cited By Web Of Science : 33  (Related Records In Web of Science)
Times Cited By SCOPUS : 31
연도 인용수 순위
1 Ciaolfa, V. R, Zamai, M., Fiorino, E., Frigerio, E., Pellizzoni, C., d'Argy, R, Ghiglieri, A., Castelli, M. G., Farao, M., Pesenti, E., Gigli, M., Angelucci, F. and Suarato, A., Polymer-bound camptothecin: initial biodistribution and antitumor activity studies. J. Control. Release, 65,105-119 (2000)   DOI   ScienceOn
2 Ertl, B., Platzer, P., Wirth, M. and Gabor, F, Poly(D,L-lactic-coglycolic acid) microspheres for sustained delivery and stabilization of camptothecin. J. Control. Release, 61, 305-317(1999)   DOI   ScienceOn
3 Gabizon, A., Goren, D., Horowitz, A. T., Tzemach, D., Lossos, A and Siegal, T., Long-circulating liposomes for drug delivery in cancer therapy: a review of biodistribution studies in tumor-bearing animals. Adv. Drug Deliv. Rev., 24, 337-344 (1997)   DOI   ScienceOn
4 Leamon, C. P. and Low, P S., Folate-mediated targeting: from diagnostics to drug and gene delivery. Drug Discov. Today, 6,44-51 (2001)   DOI   ScienceOn
5 Miglietta, A., Cavalli, R., Bocca, C., Gabriel, L. and Gasco, M. R., Cellular uptake and cytotoxicity of solid lipid nanospheres (SLN) incorporating doxorubicin or paclitaxel. Int. J. Pharm. 210, 61-67 (2000)   DOI   PUBMED   ScienceOn
6 Forssen, E., The design and development of DaunoXome for solid tumor targeting in vivo. Adv. Drug Deliv. Rev., 24, 133-150(1997)   DOI   ScienceOn
7 Emerich, D. F, Winn, S. R., Snodgrass, P., LaFreniere, D., Agostino, M., Wiens, T., Xiong, H. and Bartus, R. T., Injectable chemotherapeutic microspheres and glioma II: Enhanced survival following implantation into deep inoperable tumors. Pharm. Res., 17, 776-781 (2000)   DOI   ScienceOn
8 Brigger, I., chaminade, P., Marsaud, V., Appel, M., Besnard, M., Gurny, R., Renoir, M. and Couvreur, P., Tamoxifen encapsulation within polyethylene glycol-coated nanospheres. A new antiestrogen formulation. Int. J. Pharm., 214, 37-42 (2001)   DOI   PUBMED   ScienceOn
9 Chan, C. K., Hubner, S., Hu, W. and Jans, D. A, Mutual exclusivity of DNA binding and nuclear localization signal recognition by the yeast transcription factor GAL4: implications for nonviral DNA delivery. Gene Ther., 5, 1204-12(1998)   DOI   ScienceOn
10 Curnis, F, Sacchi, A., Borgna, L., Magni, F., Gasparri, A. and Corti, A., Enhancement of tumor necrosis factor antitumor immunotherapeutic properties by targeted delivery to amino-peptidase N (CD 13). Nature Biotech., 18, 1185-1190 (2000)   DOI   ScienceOn
11 Etrych, T., Jellnkova, M., ihova, B. and Ulbrich, K., New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage: synthesis and preliminary in vitro and in vivo biological properties. J. Control. Release, 73, 89-102 (2001)   DOI   ScienceOn
12 Fisher, K. D., Stallwood, Y, Green, N. K., Ulbrich, K., Mautner, V. and Seymour, L. W., Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies. Gene Ther., 8, 341-348 (2001)   DOI   ScienceOn
13 Ichida, T, Kato, M., Hayakawa, A., Ito, S., Mori, S., Sato, T., Sugitani, S., Sato, H., Watanabe, M. and Asakura, H., Therapeutic effect of a CDDP-epirubicin-Lipiodol emulsion on advanced hepatocellular carcinoma. Cancer Chemother. Pharmacol., 33 Suppl, S74-78 (1994)   DOI   PUBMED
14 Julyan, P. J., Seymour, L. W., Ferry, D. R., Daryani, S., Boivin, C. M., Doran, J., David, M., Anderson, D., Christodolou, C., Young, A. M., Hesselwood, S. and Kerr, D. J., Preliminary clinical study of the distribution of HPMA copolymers bearing doxorubicin and galactosamine. J. Control. Release, 57, 281-290(1999)   DOI   ScienceOn
15 Lundberg, B., A submicron lipid emulsion coated with amphipathic polyethyelne glycol for parenteral administraiton of paclitaxel. J. Pharm. Pharmacol., 49,16-21 (1997)   DOI   PUBMED   ScienceOn
16 Kanter, P. M., Klaich, G. M. and Bullard, G. A., Liposome encapsulated vincristine: Preclinical toxicologic and pharmacologic comparison with free vincristine and empty liposomes in mice, rats and dogs. Anticancer Drugs, 5, 579-590 (1994)   DOI   ScienceOn
17 Kim, C. K., Cho, Y. J. and Gao, Z. G., Preparation and evaluation of biphenyl dimethyl dicarboxylate microemulsions for oral delivery. J. Control. Release, 70, 149-155, 2001   DOI   PUBMED   ScienceOn
18 le Visage, C., Bernard, M., Michael, H. and Kam, L., Intravesical administration of paclitaxel encapsulated in poly(methylidene malonate 2.1.2) microparticles. Ann. Biomed. Eng., 28, S-21(2000)
19 Lundberg, B. B., Griffiths, G. and Hansen, H. J., Conjugation of an anti-B-cell lymphoma monoclonal antibody, LL2, to long-circulating drug-carrier lipid emulsions. J. Pharm Pharmacol. 51,1099-105 (1999)   DOI   PUBMED
20 Miwa, A., Ishibe, A., Nakano, M., Yamahira, T., Itai, S., Jinno, S. and Kawahara, H., Development of novel chitosan derivatives as micellar carriers of taxol. Pharm. Res., 15, 1844-1850(1998)   DOI   ScienceOn
21 Noguchi, Y., Wu, J., Duncan, R., Strohalm, J., Ulbrich, K., Akaike, T. and Maeda, H., Early phase tumor accumulation of macromolecules: a great difference in clearance rate between tumor and normal tissues. Jpn. J. Cancer Res., 89,307-314 (1998)   DOI   PUBMED
22 Plank, C., Oberhauser, B., Mechtler, K., Koch, C. and Wagner, E., The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer system. J. Biol. Chem., 269,12918-12924 (1994)   PUBMED
23 Prasmickaite, L., Hogset, A. and Berg, K., Evaluation of different photosensitizers for use in photochemical gene transfection. Photochem. Photobiol., 73, 388-395 (2001)   DOI   ScienceOn
24 Wang, C. C., Li, J., Teo, C. S. and Lee, T., The delivery of BCNU to brain tumors. J. Control. Release, 61, 21-41 (1999)   DOI   PUBMED   ScienceOn
25 Provoda, C. J. and Lee, K. D., Bacterial pore-forming hemolysins and their use in the cytosolic delivery of macromolecules. Adv. Drug Deliv. Rev., 41,209-221 (2000)   DOI   ScienceOn
26 Sato, Y., Yamauchi, N., Takahashi, M., Sasaki, K., Fukaura, J., Neda, H., Fujii, S., Hirayama, M., Itoh, Y., Koshita, Y., Kogawa, K., Kato, J., Sakamaki, S. and Niitsu, Y., In vivo gene delivery to tumor cells by transferrin-streptavidin-DNA conjugate. FASEB J., 14, 2108-2118 (2000)   DOI   ScienceOn
27 Smith, J. P., Kanekal, S., Patawaran, M. B., Chen, J. Y., Jones, R. E., Orenberg, E. K. and Yu, N. Y., Drug retention and distribution after intratumoral chemotherapy with fluorouracil/epinephrine injectable gel in human pancreatic cancer xenografts. Cancer Chemother Pharmacol., 44, 267-274(1999)   DOI   ScienceOn
28 Ward, C. M., Acheson, N. and Seymour, L. W., Folic acid targeting of protein conjugates into ascites tumour cells from ovarian cancer patients. J. Drug Targeting, 8, 119-123(2000)   DOI   ScienceOn
29 Wong, B. K., Defeo-Jones, D., Jones, R. E., Garsky, V. M., Feng, D.-M., Oliff, A., Chiba, M., Ellis, J. D. and Lin, J. H., PSA-specific and non-PSA-specific conversion of a PSA-targeted peptide conjugate of doxorubicin to its active metabolites. Drug Metab. Dispos., 29, 313-318 (2001)   PUBMED
30 Yang, S., Zhy, J., Lu, Y., Liang, B. and Yang, C., Body distribution of camptothecin solid lipid nanoparticles after oral administration. Pharm. Res., 16,751-757 (1999)   DOI   ScienceOn
31 Yi, S. W., Kim, Y H., Kwon, I. C., Chung, J. W., Park, J. H., Choi, Y W. and Jeong, S. Y., Stable lipiodolized emulsions for hepatoma targeting and treatment by transcatheter arterial chemoembolization. J. Control. Release, 50,135-143(1998)   DOI   PUBMED   ScienceOn
32 Kong, G., Braun, R. D. and Dewhirst, M. W., Hyperthermia enables tumor-specific nanoparticle delivery: Effect of particle size. Cancer Res., 60,4440-4445 (2000)   PUBMED
33 Giles R. V.. Spiller, D. G., Grzybowski, J., Clark, R. E., Nicklin, P. and Tidd, D. M., Selecting optimal oligonucleotide com-position for maximal antisense effect following streptolysin O-mediated delivery into human leukaemia cells. Nucl. Acids Res., 26, 1567-1575 (1998)   DOI   ScienceOn
34 Higashi, S., Tabata, N., Kondo, K. H., Maeda, Y., Shimizu, M., Nakashima, T. and Setoguchi, T., Size of lipid microdroplets effects results of hepatic arterial chemotherapy with an anticancer agent in water-in-oil-in-water emulsion to hepatocellular carcinoma. J. Pharmacal. Exp. Ther., 289, 816-819(1999)
35 Miller, M., Targeted cancer therapies attempt to hit the bull's-eye. J. Natl. Cancer Inst., 92, 1878-1879 (2000)   DOI   PUBMED   ScienceOn
36 stastny, M., Strohalm, J., Plocova, D., Ulbrich, K. and Oihova, B., A possibility to overcome P-glycoprotein (PGP)-mediated multidrug resistance by antibody-targeted drugs conjugated to HPMA copolymer carrier. Eur. J. Cancer, 35, 459-466(1999)   DOI   ScienceOn
37 Torchilin, V. P., Polymer-coated long-circulating microparticulate pharmaceuticals. J Microencapsul., 15, 1-19 (1998)   DOI   PUBMED   ScienceOn
38 Elliott, G. and O'Hare, P, Intracellular trafficking and protein delivery by a herpesvirus structural protein. Cell, 88, 223-233 (1997)   DOI   ScienceOn
39 Kim, C. K., Choi, Y. J., Lim, S. J., Lee, M. G., Lee, S. H. and Hwang, S. J. Lymph nodes targeting and pharmacokinetics of $^{3}H$-methotrexate-encapsulated neutral large unilamellar vesicles and immunoliposomes. Int. J. Pharm., 98, 9-18(1993)   DOI   ScienceOn
40 Kim, C. K., Lee, M. K., Han, J. H. and Lee, B. J., Pharmacokinetics and tissue distribution of methotrexate after intravenous injection of differently charged liposome-entrapped methotrexate to rats. Int. J. Pharm., 108, 21-29, 1994   DOI   ScienceOn
41 Reed, D. S., Romero, P., Rimoldi, D., Cerottini, J. C., Schaack, J. and Jongeneel, C. V., Construction and characterization of a recombinant adenovirus directing expression of the MAGE-1 tumor-specific antigen. Int. J. Cancer., 72, 1045-1055 (1997)   DOI   ScienceOn
42 Greco, O. and Dachs, G. U., Gene directed enzyme/prodrug therapy of cancer: Historical appraisal and future prospectives. J. Cell. Physiol., 187, 22-36 (2001)   DOI   ScienceOn
43 De Rosa, F S., Marchetti, J. M., Thomazini, J. A., Tedesco, A. C. and Bentley, M. V., A vehicle for photodynamic therapy of skin cancer: influence of dimethylsulphoxide on 5-amino-levulinic acid in vitro cutaneous permeation and in vivo protoporphyrin IX accumulation determined by confocal microscopy. J. Control. Release, 65, 359-366 (2000)   DOI   ScienceOn
44 Ceruti, M., Crosasso, P., Brusa, P., Arpicco, S., Dosia, F and Cattel, L., Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing water-soluble prodrugs of paclitaxel. J. Control. Release, 63, 141-153 (2000)   DOI   PUBMED   ScienceOn
45 Sludden, J., Uchegbu, I. F. and Schatzlein, A. G., The encapsulation of bleomycin within chitosan based polymeric vesicles does not alter its biodistribution. J. Pharm. Pharmacol., 52, 377-382 (2000)   DOI   ScienceOn
46 Harada, Y., Iwai, M., Tanaka, S., Okanoue, T., Kashima, K., Maruyama-Tabata, H., Hirai, H., Satoh, E., Imanishi, J. and Mazda, O., Highly efficient suicide gene expression in hepatocellular carcinoma cells by epstein-barr virus-based plasmid vectors combined with polyamidoamine dendrimer. Cancer Gene Ther., 7, 27-36 (2000)   DOI   ScienceOn
47 Kaneda, Y., Virosomes: evolution of the liposome as a targeted drug delivery system. Adv. Drug Deliv. Rev., 43, 197-205 (2000)   DOI   PUBMED   ScienceOn
48 Robert, L., Peacock, G. G. and Lu, D. R., Targeted drug delivery for brain cancer treatment. J. Control. Release, 65, 31-41(2000)   DOI   PUBMED   ScienceOn
49 Yoo, H. S. and Park, T G., Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA-PEG block copolymer. J. Control. Release, 70, 63-70 (2001)   DOI   PUBMED   ScienceOn
50 Fan, H. and Dash, A. K., Effect of cross-linking on the in vitro release kinetics of doxorubicin from gelatin implants. Int. J. Pharm., 213, 103-116 (2001)   DOI   PUBMED   ScienceOn
51 Gruenberq, J. and Maxfield, F. R., Membrane trasport in the endocytic pathway. Curr. Opn. Cell Biol., 7, 552-563 (1995)   DOI   ScienceOn
52 Han, J. H., Oh, Y. K, Kim, D. S. and Kim, C. K., Enhanced hepatocyte uptake and liver targeting of methotrexate using galactosylated albumin as a carrier. Int. J. Pharm., 188, 39-47(1999)   DOI   ScienceOn
53 Ichinose, K., Tomiyama, N., Nakashima, M., Ohya, Y., Ichikawa, M., Ouchi, T. and Kanematsu, T, Antitumor activity of dextran derivatives immobilizing platinum complex (II). Anti-Cancer Drugs, 11, 33-38 (2000)   DOI   ScienceOn
54 Warren, L., Jardillier, J.-C., Malarska, A. and Akeli, M. G., Increased accumulation of drugs in multidrug resistant cells induced by liposomes. Cancer Res., 52, 3241-3245 (1992)   PUBMED
55 Woodle, M. C., Controlling liposomal blood clearance by surface-grafted polymers. Adv. Drug Deliv. Rev., 32, 139-152(1998)   DOI   ScienceOn
56 Skubitz, K. M. and Anderson, P. M., Inhalational interleukin-2 liposomes for pulmonary metastases: a phase I clinical trial. Anticancer Drugs, 11, 555-563 (2000)   DOI   ScienceOn
57 Kim, C. K. and Han, J.-H., Lymphatic delivery and pharmacokinetics of methotrexate after intramuscular injection of differently charged liposome-entrapped methotrexate to rats. J. Microencapsul., 12, 437-446 (1995)   DOI   ScienceOn
58 Huang, C. M., Wu, Y.-T. and Chen, S. T., Targeting delivery of paclitaxel into tumor cells via somatostatin receptor endocytosis. Chem. Biol. 7, 453-461 (2000)   DOI   ScienceOn
59 Koller-Lucae, S. K., Schott, H. and Schwendener, R. A., Low density lipoprotein and liposome mediated uptake and cytotoxic effect of N4-octadecyl-1-beta-D-arabinofuranosyl-cytosine in Daudi lymphoma cells. Br. J. Cancer, 80, 1542-1549(1999)   DOI   ScienceOn
60 Oki, N., Anticancer therapy using glucuronate modified long-circulating liposomes. Adv. Drug Deliv. Rev., 40, 63-73(1999)   DOI   PUBMED   ScienceOn
61 Rosenkranz, A. A., Jans, D. A. and Sobolev, A. S., Targeted intracellular delivery of photosensitizers to enhance photodynamic efficiency. Immunol. Cell Biol., 78, 452-464 (2000)   DOI   ScienceOn
62 Yapp, D. T., Lloyd, D. K., Zhu, J. and Lehnert, S. M., Cisplatin delivery by biodegradable polymer implant is superior to systemic delivery by osmotic pump or i.p. injection in tumor-bearing mice. Anticancer Drugs, 9, 791-796 (1998)   DOI   ScienceOn
63 Kim, C. K., Haider, K. H. and Lim, S. J., Gene medicine: a new field of molecular medicine. Arch. Pharm. Res., 24, 1-15 (2001)   DOI   ScienceOn
64 Kondoh, M., Matsuyama, T., Suzuki, R., Mizuguchi, H., Nakanishi, T., Nakagawa, S., Tsutsumi, Y., Nakanishi, M., Sato, M. and Mayumi, T., Growth inhibition of human leukemia HL-60 cells by an antisense phosphodiester oligonucleotide encapsulated into fusogenic liposomes. Biol. Pharm. Bull., 23,1011-1013 (2000)   DOI   PUBMED   ScienceOn
65 Siemens, D. R., Austin, J.C., Hedican, S. P., Tartaglia, J. and Ratliff, T. L., Viral vector delivery in solid-state vehicles: Gene expression in a murine prostate cancer model. J. Natl. Cancer Inst., 92, 403-412 (2000)   DOI   ScienceOn
66 Trotta, M., Pattarino, F. and Gasco, M. R., Influence of counter ions on the skin permeation of methotrexate from water-oil microemulsions. Pharm. Acta Helv., 71,135-140 (1996)   DOI   ScienceOn
67 Conover, C. D., Greenwald, R. B., Pendri, A. and Shum, K. L., Camptothecin delivery systems: the utility of amino acid spacers for the conjugation of camptothecin with polyethlene glycol to create prodrugs. Anticancer Drug Res., 14, 499-506 (1999)
68 Delie, F, Berton, M., Allemann, E. and Gurny, R, Comparison of two methods of encapsulation of an oligonucleotide into poly(,-lactic acid) particles. lnt. J. Pharm., 214, 25-30 (2001)   DOI   ScienceOn
69 Pechar, M., Ulbrich, K., Subr, V., Seymour, L. W. and Schacht, E. H., Poly(ethylene glycol) multiblock copolymer as a carrier of anti-cancer drug doxorubicin. Bioconjug. Chem., 11, 131-139(2000)   DOI   ScienceOn
70 Maheshwari, A., Mahato, R. I., McGregor, J., Han, S. O., Samlowski, W. E., Park, J. S. and Kim, S. W., Soluble biodegradable polymer-based cytokine gene delivery for cancer treatment. Mol. Therapy, 2,121-130 (2000)   DOI   ScienceOn
71 Sugano, M., Egilmez, N. K., Yokota, S. J., Chen, F.-A., Harding, J., Huang, S. K. and Bankert, R. B., Antibody targeting of coxorubicin-loaded liposomes suppresses the growth and metastatic spread of established human lung tumor xenografts in severe combined immunodeficient mice. Cancer Res., 60, 6942-6949 (2000)   PUBMED
72 Straubinger, R. M., pH-sensitive liposomes for delivery of macromolecules into cytoplasm of culture cells. Methods Enzymol., 221, 361-376 (1993)   DOI   PUBMED
73 Wyman, T B., Nicol, F., Zelphati, O., Scaria, P. V., Plank, C. and Szoka Jr., F. C., Design, synthesis, and characterization of a cationic peptide that binds to nucleic acids and permeabilizes bilayers. Biochemistry, 36, 3008-3017 (1997)   DOI   ScienceOn
74 Fukushima, S., Kishimoto, S., Takeuchi, Y. and Fukushima, M., Preparation and evaluation of o/w type emulsions containing antitumor prostaglandin. Adv. Drug Deliv. Rev., 45, 65-75(2000)   DOI   ScienceOn
75 Goren, D., Horowitz, A. T., Tzemach, D., Tarshish, M., Zalipsky, S. and Gabizon, A., Nuclear delivery of doxorubicin via folate-targeted Iiposomes with bypass of multidrug-resistarce efflux pump. Clin. Cancer Res., 6, 1949-1957 (2000)   PUBMED
76 Martinez-Fong, D., Navarro-Quiroga, I., Ochoa, I., Alvarez-Maya, I., Meraz, M. A., Luna, J. and Arias-Montano, J. A., Neurotensin-SPDP-poly-L-lysine conjugate: a nonviral vector for targeted gene delivery to neural cells. Brain Res. Mol. Brain Res., 69, 249-262 (1999)   DOI   PUBMED   ScienceOn
77 Cuvier, C., Roblot-Treupel, L., Millot, J. M., Lizard, G., Chevillard, S., Manfait, M., Couvreur, P. and Poupon, M. F, Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance. Biochem. Pharmacol., 44,509-517 (1992)   DOI   ScienceOn
78 Bue, P., Holmberg, A. R., Marquez, M., Westlin, J. E., Nilsson, S. and Malmstrom, P. U., Intravesical administration of EGF-dextran conjugates in patients with superficial bladder cancer. Eur. Urol., 38, 584-589 (2000)   DOI   ScienceOn
79 Chandy, T., Das, G. S. and Rao, G. H., 5-Fluorouracil-loaded chitosan coated polylactic acid microspheres as biodegradable drug carriers for cerebral tumours. J. Microencapsul., 17, 625-638 (2000)   DOI   ScienceOn
80 Constantinides, P. P., Lambert, K. J., Tustian, A. K., Schneider, B., Lalji, S., Ma, w., Wentzel, B., Kessler, D., Worah, D. and Quay, S. C., Formulation development and antitumor activity of a filter-sterilizable emulsion of paclitaxel. Pharm. Res., 17, 175-182 (2000)   DOI   ScienceOn
81 Fundaro, A, Cavalli, R., Bargoni, A., Vighetto, D., Zara, G. P. and Gasco, M. R., Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: Pharmacokinetics and tissue distribution after i.v. administration to rats. Pharmacol. Res., 42,337-343 (2000)   DOI   ScienceOn
82 Denis-Mize, K. S., Dupuis, M., MacKichan, M. L., Singh, M., Doe, B., O'Hagan, D., Ulmer, J. B., Donnelly, J. J., McDonald, D. M. and Ott, G., Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells. Gene Ther., 7, 2105-2112(2000)   DOI   ScienceOn
83 Hong, R. L. and Tseng, Y. L., Phase I and pharmacokinetic study of a stable, polyethylene-glycolated liposomal doxorubicin in patients with solid tumors: the relation between pharmaco-kinetic property and toxicity. Cancer, 91, 1826-1833 (2001)   DOI   PUBMED   ScienceOn
84 Kataoka, K., Matsumoto, T., Yokoyama, M., Okano, T., Sakurai, Y., Fukushima, S., Okamoto, K. and Kwon, G. S., Doxorubicin-loaded poly(ethylene glycol)-poly(beta-benzyl-L-aspartate)copolymer micelles: their pharmaceutical characteristics and biological significance. J. Control. Release, 64, 143-153(2000)   DOI   ScienceOn
85 Lu, J. M., Peterson, C. M., Shiah, J. G., Gu, Z.-W, Peterson, C. A., Straight, R. C. and Kopeeek, J., Cooperativity between free and N-(2-hydroxypropyl) methacrylamide copolymer bound adriamycin and mesochlorin $e_{6}$ monothylene diamine induced photodynamic therapy in human epithelial ovarian carcinoma in vivo. Int. J. Oncol., 15,5-16 (1999)   PUBMED
86 Koshkina, N. V., Kleinerman, E. S., Waidrep, C., Jia, S. F., Worth, L. L., Gilbert, B. E. and Knight, V., 9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice. Clin. Cancer Res., 6, 2876-2880(2000)   PUBMED
87 Kreuter, J., Nanoparticulate systems for brain delivery of drugs. Adv. Drug Deliv. Rev., 47,65-81 (2001)   DOI   PUBMED   ScienceOn
88 van Slooten, M. L., Boerman, O., Romoren, K., Kedar, E., Crommelin, D. J. A. and Storm, G., Liposomes as sustained release system for human interferon-g: biopharmaceutical aspects. Biochim. Biophys. Acta, 1530, 134-145 (2001)   DOI   PUBMED   ScienceOn
89 Alakhov, V. Y., Moskaleva, E. Y., Batrakova, E. V. and Kabanov, A V., Hypersensitization of multidrug resistant human ovarian carcinoma cells by Pluronic P85 block copolymer. Bioconjug. Chem., 7, 209-216 (1996)   DOI   ScienceOn
90 Bielinska, A., Kukowska-Latallo, J. F., Johnson, J., Tomalia, D. A. and Baker Jr., J. R., Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers. Nucl. Acids. Res., 24, 2176-2182 (1996)   DOI   ScienceOn
91 Lim, C. R., Kim, C.-K., Oh, K. H., Yuk, S. H. and Lee, H. B., The enhancement of liver targetability of $[^{3}H]$-methotrexate-galactosylated bovine serum albumin conjugate in mice. Int. J. Pharm., 132, 175-182 (1996)   DOI   ScienceOn
92 Minko, T., Kopeekova, P.and Kopeeek, J., Efficacy of chemotherapeutic action of HPMA copolymer-bound doxorubicin in a solid tumor model of ovarian carcinoma. Int. J. Cancer., 86, 108-117 (2000)   DOI   ScienceOn
93 Egilmez, N. K., Jong, Y. S., Sabel, M. S., Jacob, J. S., Mathiowitz, E. and Bankert, R. B., In situ tumor vaccination with interleukin-12-encapsulated biodegradable microspheres: Induction of tumor regression and potent antitumor immunity. Cancer Res., 60, 3832-3837 (2000)   PUBMED
94 Finlay, I. G., Stewart, G. J., Pourgholami, M. H., Akhter, J. and Morris D. L., The use of lipiodol and medium chain triglyceride as delivery agents for hepatic arterial administration of 1,25-dihydroxyvitamin D3-A potential new treatment for hepato-cellular carcinoma. Anticancer Res., 20, 2705-2709 (2000)   PUBMED
95 Harrington, K. J., Rowlinson-Busza, G., Uster, P. S. and Stewart, J. S., Pegylated liposome-encapsulated doxorubicin and cisplatin in the treatment of head and neck xenograft tumours. Cancer Chemother. Pharmacol., 46, 10-18 (2000)
96 Leroux, J. C., Roux, E., LeGarrec, D., Hong, K. and Drummond, D.C., N-isopropylacrylamide copolymers for the preparation of pH-sensitive liposomes and polymeric micelles. J. Control. Release, 72, 71-84 (2001)   DOI   PUBMED   ScienceOn
97 Zhang, X., Jackson, J. K. and Burt, H. M., Development of amphiphilic diblock copolymers as micellar carriers of taxol. Int. J. Pharm., 132, 195-206 (1996)   DOI   ScienceOn
98 Zou, Y., Ling, Y. H., Reddy, S., Priebe, W. and Perez-Soler, R., Effect of vesicle size and lipid composition on the in vivo tumor selectivity and toxicity of the non-cross-resistant anthracycline annamycin incorporated in liposomes. Int. J. Cancer, 61,666-671 (1995)   DOI   ScienceOn
99 Choi, Y., Kim, S. Y., Kim, S. H., Lee, K.-S., Kim, C. and Byun, Y., Long-term delivery of all-trans-retinoic acid using biodegradable PLLA/PEG-PLLA blended microspheres. Int. J. Pharm., 215,67-81 (2001)   DOI   PUBMED   ScienceOn